Lisa M. DeFrancesco

Insider Reports History

Location
New York, NY
Signature
/s/ Lisa M. DeFrancesco
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa M. DeFrancesco:

Company Role Class Num Shares Value Price $ Report Date Ownership
INTERCEPT PHARMACEUTICALS, INC. SVP, IR & Corp. Affairs Common Stock 10,308 $195,852 $19.00 31 Dec 2021 Direct
LEXICON PHARMACEUTICALS, INC. SVP, IR and Corp Comm Common Stock 93,869 $137,987 $1.47 28 Feb 2026 Direct
LEXICON PHARMACEUTICALS, INC. SVP, IR and Corp Comm Restricted Stock Units 256,380 $33,062 $0.6700 28 Feb 2026 Direct
LEXICON PHARMACEUTICALS, INC. SVP, IR and Corp Comm Stock Option (Right to Buy) 386,300 12 Feb 2026 Direct

Insider Reports Filed by Lisa M. DeFrancesco

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2026 5 -$109,621 4 SVP, IR and Corp Comm 03 Mar 2026, 07:18
LXRX LEXICON PHARMACEUTICALS, INC. 12 Feb 2026 2 $0 4 SVP, IR and Corp Comm 17 Feb 2026, 16:07
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2025 3 -$6,094 4 SVP, IR and Corp Comm 03 Mar 2025, 16:30
LXRX LEXICON PHARMACEUTICALS, INC. 13 Feb 2025 2 $0 4 VP, IR and Corp Comm 18 Feb 2025, 16:20
LXRX LEXICON PHARMACEUTICALS, INC. 02 Oct 2024 0 $0 3 VP, IR and Corp Strategy 07 Oct 2024, 16:58
/report/000110465922000929-defrancesco-lisa-2021-12-31 INTERCEPT PHARMACEUTICALS, INC. 31 Dec 2021 1 -$8,829 4 SVP, IR & Corp. Affairs 04 Jan 2022, 15:18
/report/000110465921122561-defrancesco-lisa-2021-09-30 INTERCEPT PHARMACEUTICALS, INC. 30 Sep 2021 1 -$3,029 4 SVP, IR & Corp. Affairs 04 Oct 2021, 17:04
/report/000110465921113041-defrancesco-lisa-2021-09-01 INTERCEPT PHARMACEUTICALS, INC. 01 Sep 2021 1 -$8,097 4 SVP, IR & Corp. Affairs 03 Sep 2021, 19:00